NORWOOD, MA-Ovid Technologies's regional headquarters will remain at 100 River Ridge Rd. After considering other options, the medical information services company renewed its lease for 23,745 sf of ...
Wolters Kluwer Health today announced the launch of new AI features in Ovid® Synthesis to further support nursing and quality improvement leaders, practitioners and researchers in elevating the ...
Ovid Therapeutics seems to have found its focus after a rough year: epilepsy. But the biotech will move toward this new direction with 20% fewer people at the company. The company announced a ...
The latest price target for Ovid Therapeutics (NASDAQ:OVID) was reported by HC Wainwright & Co. on May 27, 2025. The analyst firm set a price target for $1.50 expecting OVID to rise to within 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback